Structural insights into the molecular basis of the ligand promiscuity

Journal of Chemical Information and Modeling

Volumn 52, Issue 9, 2012, Pages 2410-2421

  Sturm, Noé ^a,b   Desaphy, Jérémy ^a   Quinn, Ronald J ^b   Rognan, Didier ^a   Kellenberger, Esther ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BINDING SITES; PHYSICOCHEMICAL PROPERTIES; PROTEINS;

BIOACTIVE COMPOUNDS; CHEMICAL MOIETIES; DRUG DEVELOPMENT; LIGAND-BINDING SITES; MOLECULAR COMPLEXITY; PROTEIN DATA BANK; STRUCTURAL INSIGHTS; THREE-DIMENSIONAL STRUCTURE;

LIGANDS;

LIGAND; PROTEIN;

ARTICLE; BINDING SITE; COMPUTER GRAPHICS; HEALTH SERVICE; METABOLISM;

BINDING SITES; COMPUTER GRAPHICS; LIGANDS; MENU PLANNING; PROTEINS;

EID: 84866638168     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300196g     Document Type: Article

References (52)

1. Rognan, D. Chemogenomic approaches to rational drug design Br. J. Pharmacol. 2007, 152, 38-52
2. van der Horst, E.; Peironcely, J.; van Westen, G.; van den Hoven, O.; Galloway, W.; Spring, D.; Wegner, J.; van Vlijmen, H.; Ijzerman, A.; Overington, J.; Bender, A. Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic space Curr. Top. Med. Chem. 2011, 11, 1964-1977
3. Vidal, D.; Garcia-Serna, R.; Mestres, J. Ligand-based approaches to in silico pharmacology Methods Mol. Biol. 2011, 672, 489-502
4. Campillos, M.; Kuhn, M.; Gavin, A.-C.; Jensen, L. J.; Bork, P. Drug Target Identification Using Side-Effect Similarity Science 2008, 321, 263-266
5. Kellenberger, E.; Hofmann, A.; Quinn, R. Similar Interactions of Natural Products with Biosynthetic Enzymes and Therapeutic Targets could explain why Nature produces such a Large Proportion of Existing Drugs Nat. Prod. Rep. 2011, 28, 1483-1492
6. Nicola, G.; Liu, T.; Gilson, M. K. Public Domain Databases for Medicinal Chemistry J. Med. Chem. 2012, 10.1021/jm300501t
7. Wassermann, A.; Bajorath, J. BindingDB and ChEMBL: online compound databases for drug discovery Expert. Opin. Drug. Discov. 2011, 6, 683-687
8. Bender, A.; Scheiber, J.; Glick, M.; Davies, J. W.; Azzaoui, K.; Hamon, J.; Urban, L.; Whitebread, S.; Jenkins, J. L. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure Chem. Med. Chem. 2007, 2, 861-873
9. Defranchi, E.; Schalon, C.; Messa, M.; Onofri, F.; Benfenati, F.; Rognan, D. Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements PLoS One 2010, 5, e12214
10. Keiser, M. J.; Setola, V.; Irwin, J. J.; Laggner, C.; Abbas, A. I.; Hufeisen, S. J.; Jensen, N. H.; Kuijer, M. B.; Matos, R. C.; Tran, T. B.; Whaley, R.; Glennon, R. A.; Hert, J.; Thomas, K. L. H.; Edwards, D. D.; Shoichet, B. K.; Roth, B. L. Predicting new molecular targets for known drugs Nature 2009, 462, 175-181
11. Kinnings, S. L.; Liu, N.; Buchmeier, N.; Tonge, P. J.; Xie, L.; Bourne, P. E. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis PLoS Comput. Biol. 2009, 5, e1000423
12. Lounkine, E.; Keiser, M. J.; Whitebread, S.; Mikhailov, D.; Hamon, J.; Jenkins, J. L.; Lavan, P.; Weber, E.; Doak, A. K.; Cote, S.; Shoichet, B. K.; Urban, L. Large-scale prediction and testing of drug activity on side-effect targets Nature 2012, 486, 361-367
13. Paolini, G. V.; Shapland, R. H. B.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space Nat. Biotechnol. 2006, 24, 805-815
14. Krejsa, C.; Horvath, D.; Rogalski, S.; Penzotti, J.; Mao, B.; Barbosa, F.; Migeon, J. Predicting ADME properties and side effects: the BioPrint approach Curr. Opin. Drug Discov. Devel. 2003, 6, 470-480
15. Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry Nat. Rev. Drug Discov. 2007, 6, 881-890
16. Peters, J.-U.; Hert, J.; Bissantz, C.; Hillebrecht, A.; Gerebtzoff, G. g.; Bendels, S.; Tillier, F.; Migeon, J.; Fischer, H.; Guba, W.; Kansy, M. Can we discover pharmacological promiscuity early in the drug discovery process? Drug Discovery Today 2012, 17, 325-335
17. Yang, Y.; Chen, H.; Nilsson, I.; Muresan, S.; Engkvist, O. Investigation of the relationship between topology and selectivity for druglike molecules J. Med. Chem. 2010, 53, 7709-7714
18. Young, R. J.; Green, D. V. S.; Luscombe, C. N.; Hill, A. P. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity Drug Discovery Today 2011, 16, 822-830
19. Berman, H. M.; Kleywegt, G. J.; Nakamura, H.; Markley, J. L. The Protein Data Bank at 40: Reflecting on the Past to Prepare for the Future Structure 2012, 20, 391-396
20. Meslamani, J.; Rognan, D.; Kellenberger, E. sc-PDB: a database for identifying variations and multiplicity of ″druggable″ binding sites in proteins Bioinformatics 2011, 27, 1324-1326
21. Kellenberger, E.; Foata, N.; Rognan, D. Ranking targets in structure-based virtual screening of 3-D protein libraries: Methods and Problems J. Chem. Inf. Model. 2008, 48, 1014-1025
22. The UniProt, C., Reorganizing the protein space at the Universal Protein Resource (UniProt) Nucleic Acids Res. 2012, 40, D71-D75
23. Cole, J. C.; Murray, C. W.; Nissink, J. W. M.; Taylor, R. D.; Taylor, R. Comparing protein-ligand docking programs is difficult Proteins: Struct., Funct., Bioinf. 2005, 60, 325-332
24. Marcou, G.; Rognan, D. Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints J. Chem. Inf. Model. 2006, 47, 195-207
25. Grant, J. A.; Gallardo, M. A.; Pickup, B. T. A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape J. Comput. Chem. 1996, 17, 1653-1666
26. Bourne, P. E.; Beran, B.; Bi, C.; Bluhm, W. F.; Dimitropoulos, D.; Feng, Z.; Goodsell, D. S.; Prlić, A.; B. Quinn, G.; W. Rose, P.; Westbrook, J.; Yukich, B.; Young, J.; Zardecki, C.; Berman, H. M. The evolution of the RCSB Protein Data Bank website Wiley Interdiscip. Rev. Comput. Mol. Sci. 2011, 1, 782-789
27. Mullan, L. J.; Bleasby, A. J. Short EMBOSS User Guide. European Molecular Biology Open Software Suite Brief Bioinform. 2002, 3, 92-94
28. Rost, B. Twilight zone of protein sequence alignments Protein Eng. 1999, 12, 85-94
29. Shindyalov, I. N.; Bourne, P. E. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path Protein Eng. 1998, 11, 739-747
30. Desaphy, J.; Azdimoussa, K.; Kellenberger, E.; Rognan, D. Comparison and prediction of protein-ligand binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model. 2012, 10.1021/ci300184x
31. Schalon, C.; Surgand, J.-S.; Kellenberger, E.; Rognan, D. A simple and fuzzy method to align and compare druggable ligand-binding sites Proteins: Struct., Funct., Bioinf. 2008, 71, 1755-1778
32. Weill, N.; Rognan, D. Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites J. Chem. Inf. Model. 2010, 50, 123-135
33. Gashaw, I.; Ellinghaus, P.; Sommer, A.; Asadullah, K. What makes a good drug target? Drug Discovery Today 2012, 17, S24-S30
34. Stockwell, G. R.; Thornton, J. M. Conformational diversity of ligands bound to proteins J. Mol. Biol. 2006, 356, 928-944
35. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliver. Rev. 2001, 46, 3-26
36. Ursu, O.; Rayan, A.; Goldblum, A.; Oprea, T. I. Understanding drug-likeness Wiley Interdiscip. Rev. Comput. Mol. Sci. 2011, 1, 760-781
37. Wishart, D. S. DrugBank and its relevance to pharmacogenomics Pharmacogenomics 2008, 9, 1155-1162
38. Galperin, M. Y.; Koonin, E. V. Divergence and Convergence in Enzyme Evolution J. Biol. Chem. 2012, 287, 21-28
39. Stout, T. J.; Sage, C. R.; Stroud, R. M. The additivity of substrate fragments in enzyme-ligand binding Structure 1998, 6, 839-848
40. Schüttelkopf, A. W.; Hardy, L. W.; Beverley, S. M.; Hunter, W. N. Structures of Leishmania major Pteridine Reductase Complexes Reveal the Active Site Features Important for Ligand Binding and to Guide Inhibitor Design J. Mol. Biol. 2005, 352, 105-116
41. Stubbs, M. T.; Reyda, S.; Dullweber, F.; Möller, M.; Klebe, G.; Dorsch, D.; Mederski, W. W. K. R.; Wurziger, H. pH-Dependent Binding Modes Observed in Trypsin Crystals: Lessons for Structure-Based Drug Design Chem. Bio. Chem. 2002, 3, 246-249
42. Reyda, S.; Sohn, C.; Klebe, G.; Rall, K.; Ullmann, D.; Jakubke, H.-D.; Stubbs, M. T. Reconstructing the Binding Site of Factor Xa in Trypsin Reveals Ligand-induced Structural Plasticity J. Mol. Biol. 2003, 325, 963-977
43. Jacobs, M. D.; Caron, P. R.; Hare, B. J. Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex Proteins: Struct., Funct., Bioinf. 2008, 70, 1451-1460
44. Atwell, S.; Adams, J. M.; Badger, J.; Buchanan, M. D.; Feil, I. K.; Froning, K. J.; Gao, X.; Hendle, J. r.; Keegan, K.; Leon, B. C.; Müller-Dieckmann, H. J.; Nienaber, V. L.; Noland, B. W.; Post, K.; Rajashankar, K. R.; Ramos, A.; Russell, M.; Burley, S. K.; Buchanan, S. G. A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase J. Biol. Chem. 2004, 279, 55827-55832
45. Capaldi, S.; Guariento, M.; Saccomani, G.; Fessas, D.; Perduca, M.; Monaco, H. L. A Single Amino Acid Mutation in Zebrafish (Danio rerio) Liver Bile Acid-binding Protein Can Change the Stoichiometry of Ligand Binding J. Biol. Chem. 2007, 282, 31008-31018
46. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 2012, 40, D1100-D1107
47. Selzer, P.; Roth, H.-J. r.; Ertl, P.; Schuffenhauer, A. Complex molecules: do they add value? Curr. Opin. Chem. Biol. 2005, 9, 310-316
48. Benson, M. L.; Smith, R. D.; Khazanov, N. A.; Dimcheff, B.; Beaver, J.; Dresslar, P.; Nerothin, J.; Carlson, H. A. Binding MOAD, a high-quality protein-ligand database Nucleic Acids Res. 2008, 36, D674-D678
49. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R. N.; Gilson, M. K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities Nucleic Acids Res. 2007, 35, D198-D201
50. Kahraman, A.; Morris, R. J.; Laskowski, R. A.; Favia, A. D.; Thornton, J. M. On the diversity of physicochemical environments experienced by identical ligands in binding pockets of unrelated proteins Proteins: Struct., Funct., Bioinf. 2010, 78, 1120-1136
51. Kim, K. M.; Qin, T.; Jiang, Y.-Y.; Chen, L.-L.; Xiong, M.; Caetano-Anollés, D.; Zhang, H.-Y.; Caetano-Anollés, G. Protein Domain Structure Uncovers the Origin of Aerobic Metabolism and the Rise of Planetary Oxygen Structure 2012, 20, 67-76
52. Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success J. Med. Chem. 2009, 52, 6752-6756